Loading Complete
John J. Laterra

John J. Laterra, MD

Neurology

Medical Oncology

Accepting New Patients
4.9 of 5 stars46 ratings, 16 reviews

Highlights

Languages

  • English

Gender

Male

Johns Hopkins Affiliations:

  • Johns Hopkins School of Medicine Faculty

About John J. Laterra

Professional Titles

  • Co-Director, Brain Cancer Disease Group, Sidney Kimmel Comprehensive Cancer Center
  • Director, Division of Neuro-Oncology

Primary Academic Title

Professor of Neurology

Background

As Professor of Neurology, Oncology and Neuroscience and Co-Director of the Brain Cancer Disease Group at the Johns Hopkins Kimmel Cancer Center, Dr. John Laterra focuses on the diagnosis and treatment of patients with primary brain tumors and neurological complications of systemic cancer.

Dr. Laterra is internationally recognized for his clinical expertise and research on mechanisms of brain tumor malignancy, tumor vascular biology and the identification of new therapeutic targets in gliomas. Dr. Laterra's research is funded by the National Institutes of Health and numerous private foundations.

Additional Academic Titles

Professor of Neuroscience, Professor of Oncology

Research Interests

Mechanisms of Brain Cancer Stem Cell Regulation

Selected Publications

  • Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H, Burger P and Laterra J: Reversion of human glioblastoma malignancy by U1snRNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met gene expression.  J Natl Cancer Inst, 91:1548-1556, 1999. PMID: 10491431.

  • Kim KJ, Wang L, Su, YC, Gillespie GY, Salhotra A, Lal B and Laterra J.  Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts. Clin Cancer Res, 12(4):1292-1298, 2006. PMID: 16489086

  • Li Y, Li A, Glas M, Lal B, Ying M, Sang Y, Xia S, Trageser D, Guerrero-Cázares H, Eberhart CG, Quiñones-Hinojosa A, Scheffler B, Laterra J: c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proc Natl Acad Sci U S A. 108:9951-6, 2011. PMID: 21628563; PMCID:  PMC3116406.

  • Lopez-Bertoni H, Lal B, Michelson H, Guerrero-Cázares H, Quiñones-Hinojosa A, Li Y, Laterra J. Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells. Oncogene, 2016 Feb 22. doi: 10.1038/onc.2016.22. [Epub ahead of print].

  • Zhou J, Tryggestad E, Wen Z, Lal B, Zhou T, Grossman R, Yan K, Wang S, Fu D-X, Blakeley J, Ford E, Tyler B, Laterra J, and van Zijl PCM:  Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nature Med.2011 Jan; 17(1): 130-4.  Epub Dec 19 2010.  PMID:  21170048, PMCID:  PMC3058561.

Honors

Alpha Omega Alpha

Memberships

  • Journal of Neuro-Oncology,

    Associate Editor

  • Scientific Advisory Board of the American Brain Tumor Association
  • The Society of Neuro-Oncology, Charter Member

Locations

  1. Johns Hopkins Outpatient Center
    • 601 North Caroline Street, Floor 5, Baltimore, MD 21287

    Expertise

    Education

    University of Michigan Medicine

    Residency, Neurology, 1988

    Case Western Reserve University School of Medicine

    Medical Education, MD, 1984

    Board Certifications

    Neurology

    American Board of Psychiatry and Neurology, 1990

    Insurance

    Johns Hopkins providers accept various commercial health insurance plans. However, they may not be included in all of an insurance company's plans or offerings. This may include Exchange, Medicaid, Medicare, and specific limited benefit plans. Exceptions to participation also exist based on your employer’s benefits package and the provider's location or specialty. Please contact your insurer directly to make sure your doctor is covered by your plan. For more details, please review our Insurance Information.
    Search plans
    • Aetna
    • CareFirst
    • Cigna
    • First Health
    • Geisinger Health Plan
    • HealthSmart/Accel
    • Humana
    • Johns Hopkins Health Plans
    • MultiPlan
    • Pennsylvania's Preferred Health Networks (PPHN)
    • Point Comfort Underwriters
    • Private Healthcare Systems (PHCS)
    • UnitedHealthcare
    • Veteran Affairs Community Care Network (Optum-VACCN)

    Ratings & Reviews

    4.9 out of 5

    46 ratings, 16 reviews

    The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

    Overall Rating by Patient
    Average provider Overall Rating by Patient rating 5 out of 5 stars
    Provider Listened Carefully
    Average provider Provider Listened Carefully rating 5 out of 5 stars
    Provider Explained Things Clearly
    Average provider Provider Explained Things Clearly rating 4.9 out of 5 stars
    Provider Knew Medical History
    Average provider Provider Knew Medical History rating 4.8 out of 5 stars
    Provider Showed Respect
    Average provider Provider Showed Respect rating 5 out of 5 stars
    Provider Spent Enough Time
    Average provider Provider Spent Enough Time rating 5 out of 5 stars
    Search reviews
      5 out of 5 stars
      Reviewed on 2/13/2025

      Dr. Laterra has been my primary treatment physician since 2009. Not only is he a superior physician this man truly cares about myself and his patient's. They don't come any better than John Laterra.

      5 out of 5 stars
      Reviewed on 2/6/2025

      He's the best

      5 out of 5 stars
      Reviewed on 2/6/2025

      Dr. Laterra is amazing. I honestly couldn't ask for a better specialist. He works with me to continue to treat me even as I've taken jobs outside of the United States. I have complete and total faith in his diagnoses and advice. That said I should still exercise more.

      5 out of 5 stars
      Reviewed on 1/23/2025

      World-class.

      5 out of 5 stars
      Reviewed on 12/19/2024

      Dr Laterra showed a caring side of himself and congratulated me for my honesty regarding the treatment plan.

      5 out of 5 stars
      Reviewed on 11/14/2024

      Caring yet informative.

      5 out of 5 stars
      Reviewed on 11/14/2024

      Dr Laterra is an excellent doctor, and he caring

      5 out of 5 stars
      Reviewed on 11/7/2024

      Dr Laterra is excellent. Caring, patient, explains clearly & well.

      5 out of 5 stars
      Reviewed on 10/24/2024

      Feel luck to have the care team that I do.

      5 out of 5 stars
      Reviewed on 10/17/2024

      Dr. Laterra was very attentive and helpful. He explained information clearly and showed concern.

      5 out of 5 stars
      Reviewed on 9/12/2024

      Very good with those who are battling cancer.

      5 out of 5 stars
      Reviewed on 9/5/2024

      I trust his knowledge and expertise and think he is an excellent physician. He always takes my concerns into account.

      5 out of 5 stars
      Reviewed on 7/18/2024

      Caring, understanding, informative, brilliant. There is no one I would trust more for my care. Dr Laterra is wonderful, and I am so grateful to have him leading me through my brain cancer experience.

      5 out of 5 stars
      Reviewed on 6/13/2024

      Dr. Laterra is one of the finest physicians at Hopkins

      5 out of 5 stars
      Reviewed on 6/6/2024

      Dr Laterra, has always made me feel that is there for me and my family. We have been on this journey for going on 14 years. hopefully many more to come

      5 out of 5 stars
      Reviewed on 4/25/2024

      Dr.Lattera is a wonderful man as well as doctor dr